Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review

被引:6
作者
Li, Yunheng [1 ]
Li, Hui [1 ]
He, Qiaojun [1 ]
Yang, Xiaochun [1 ,2 ,3 ,4 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Ctr Drug Safety Evaluat & Res, Hangzhou 310058, Peoples R China
[2] Zhejiang Univ, Innovat Inst Artificial Intelligence Med, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China
[3] Zhejiang Univ, Shandong Linyi Inst Modern Agr, Linyi 276000, Peoples R China
[4] Zhejiang Univ, Hangzhou Inst Innovat Med, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; immunotherapy; immune suppression; TME; natural products; TRADITIONAL CHINESE MEDICINE; HEPATIC STELLATE CELLS; REGULATORY T-CELLS; MACROPHAGE POLARIZATION; PD-L1; EXPRESSION; IMMUNE-RESPONSE; M2; POLARIZATION; CURCUMIN ANALOG; LIVER-CANCER; IN-VITRO;
D O I
10.3390/molecules28010195
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC), the most prevalent subtype of liver cancer, is the second main reason for cancer-related deaths worldwide. In recent decades, sufficient evidence supported that immunotherapy was a safe and effective treatment option for HCC. However, tolerance and frequent recurrence and metastasis occurred in patients after immunotherapy due to the complicated crosstalk in the tumor immunosuppressive microenvironment (TIME) in HCC. Therefore, elucidating the TIME in HCC and finding novel modulators to target TIME for attenuating immune suppression is critical to optimize immunotherapy. Recently, studies have shown the potentially immunoregulatory activities of natural compounds, characterized by multiple targets and pathways and low toxicity. In this review, we concluded the unique role of TIME in HCC. Moreover, we summarized evidence that supports the hypothesis of natural compounds to target TIME to improve immunotherapy. Furthermore, we discussed the comprehensive mechanisms of these natural compounds in the immunotherapy of HCC. Accordingly, we present a well-grounded review of the naturally occurring compounds in cancer immunotherapy, expecting to shed new light on discovering novel anti-HCC immunomodulatory drugs from natural sources.
引用
收藏
页数:33
相关论文
共 184 条
[1]   EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism [J].
Adams, BK ;
Cai, JY ;
Armstrong, J ;
Herold, M ;
Lu, YJ ;
Sum, AM ;
Snyder, JR ;
Liotta, DC ;
Jones, DR ;
Shoji, M .
ANTI-CANCER DRUGS, 2005, 16 (03) :263-275
[2]  
[Anonymous], 2021, CANCER, V7, DOI [10.1038/s41523-021-00291-z, DOI 10.1038/S41523-021-00291-Z]
[3]   Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma [J].
Bailly, Christian .
CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 325
[4]   Dysfunction of antigen processing and presentation by dendritic cells in cancer [J].
Bandola-Simon, Joanna ;
Roche, Paul A. .
MOLECULAR IMMUNOLOGY, 2019, 113 :31-37
[5]   Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts [J].
Bhattacharyya, Sankar ;
Hossain, Dewan Md Sakib ;
Mohanty, Suchismita ;
Sen, Gouri Sankar ;
Chattopadhyay, Sreya ;
Banerjee, Shuvomoy ;
Chakraborty, Juni ;
Das, Kaushik ;
Sarkar, Diptendra ;
Das, Tanya ;
Sa, Gaurisankar .
CELLULAR & MOLECULAR IMMUNOLOGY, 2010, 7 (04) :306-315
[6]   Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma [J].
Bishayee, Anupam ;
Politis, Themos ;
Darvesh, Altaf S. .
CANCER TREATMENT REVIEWS, 2010, 36 (01) :43-53
[7]   Sex hormone regulation of innate lymphoid cells [J].
Blanquart, Eve ;
Laffont, Sophie ;
Guery, Jean-Charles .
BIOMEDICAL JOURNAL, 2021, 44 (02) :144-156
[8]   Quercetin inhibits a large panel of kinases implicated in cancer cell biology [J].
Boly, Rainatou ;
Gras, Thierry ;
Lamkami, Touria ;
Guissou, Pierre ;
Serteyn, Didier ;
Kiss, Robert ;
Dubois, Jacques .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (03) :833-842
[9]   Paying a Price Twice: Dose-Dependent Effects of Treg Cell-Derived TGF-β on Tolerance [J].
Brown, Hailey ;
Esterhazy, Daria .
IMMUNITY, 2020, 53 (06) :1128-1130
[10]   CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition [J].
Buchbinder, Elizabeth I. ;
Desai, Anupam .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01) :98-106